Lexicon Pharmaceuticals
LXRX
LXRX
126 hedge funds and large institutions have $122M invested in Lexicon Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8.81% less ownership
Funds ownership: 82.34% → 73.53% (-8.8%)
44% less capital invested
Capital invested by funds: $220M → $122M (-$97.6M)
Holders
126
Holding in Top 10
1
Calls
$358K
Puts
$52K
Top Buyers
| 1 | +$1.12M | |
| 2 | +$650K | |
| 3 | +$541K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$372K |
| 5 |
MAM
Monaco Asset Management
Monaco
|
+$338K |
Top Sellers
| 1 | -$8.03M | |
| 2 | -$6.64M | |
| 3 | -$2.83M | |
| 4 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$1.76M |
| 5 |
PA
Pinnacle Associates
New York
|
-$632K |
